VMP 8661411000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Magnesium glycerophosphate (magnesium 97.2mg/5ml (4mmol/5ml)) oral solution
BNF code 0905013G0AADCDC
Virtual Therapeutic Moiety Magnesium glycerophosphate
Abbreviated name Mag glycerophos (mag 97.2mg/5ml (4mmol/5ml)) soln
Basis of preferred name Other
Date of name applicability 16 Mar 2010
Previous name Magnesium glycerophosphate 97.2mg/5ml (magnesium 4mmol/5ml) oral solution
Basis of previous name Other
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Continuous
Virtual Product Ingredient
Ingredient Magnesium glycerophosphate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 72717003
Strength value numerator 19.440
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solution.oral
Dose Form
Formulation Oral solution
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
MagnaPhos 97.2mg/5ml (4mmol/5ml) oral solution (TriOn Pharma Ltd)
Magnesium glycerophosphate (magnesium 97.2mg/5ml (4mmol/5ml)) oral solution (Drug Tariff Special Order)
Virtual Medicinal Product Packs
Magnesium glycerophosphate (magnesium 97.2mg/5ml (4mmol/5ml)) oral solution 1 ml
Magnesium glycerophosphate (magnesium 97.2mg/5ml (4mmol/5ml)) oral solution 200 ml

dm+d data retrieved from TRUD: release NHSBSA_6.3.0_20240624000001, imported on 24th June 2024 at 05:06:11.

Feedback